Oxervate Kit
Product Images NDC 71981-001

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Oxervate (NDC 71981-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Domp� Farmaceutici S.p.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxervate Carton (Oxervate Carton)

Packaging label for OXERVATE 0.002% (20 mcg/mL) cenegermin-bkbj ophthalmic solution. The box design includes text indicating it contains seven 1 mL multiple-dose vials, is sterile, and intended for topical application in the eye. Manufactured by Dompé farmaceutici S.p.A. and distributed by Dompé U.S. Inc.*

FDA Label Image

Oxervate Delivery System Kit (Oxervate Kit)

The packaging label for OXERVATE (cenegermin-bkbj ophthalmic solution) 0.002% (20 mcg/mL) by Dompè farmaceutici S.p.A. is shown. The label features white and blue panels with branding, active ingredient, and concentration information. It indicates the product is a weekly delivery system kit with vial adapters, pipettes, and disposable wipes included. The label states the product is Rx only.*

FDA Label Image

Ifu Steps 11 And 12 (Oxervate Step11 12)

An instructional line drawing showing two hands preparing an eye drop bottle. One hand holds the bottle upside down, while the other hand pulls off a cap, demonstrating how to open or use ophthalmic solution drops.*

FDA Label Image

Ifu Step 13 (Oxervate Step13)

An instructional diagram showing how to open or prepare a dropper bottle. It illustrates a hand twisting the cap in a clockwise direction while pulling upward to remove it from the bottle.*

FDA Label Image

Ifu Step 14 (Oxervate Step14)

An instructional line drawing showing two hands administering eye drops to an open eye. The left side illustrates squeezing a drop from a bottle held above the eye, while the right side demonstrates using a finger to gently pull down the lower eyelid before drop application.*

FDA Label Image

Ifu Step 16 (Oxervate Step16)

An instructional illustration showing a small ophthalmic dropper bottle alongside a thermometer icon indicating recommended storage temperature between 2°C (36°F) and 25°C (77°F) for proper handling of the solution.*

FDA Label Image

Ifu Step 18 (Oxervate Step18)

An instructional illustration showing an ophthalmic dropper bottle next to a clock symbol indicating a 12-hour interval, likely representing dosing frequency or timing of administration for the eye drops.*

FDA Label Image

Ifu Step 19 (Oxervate Step19)

A chart depicting multiple rows and columns with icons resembling droplets. The chart appears to represent dosage or administration frequency, likely related to the ophthalmic solution drops of OXERVATE (cenegermin-bkbj) 20 mcg/mL by Dompè farmaceutici S.p.A. Specific values and labels are not fully legible.*

FDA Label Image

Ifu Step 3 (Oxervate Step3)

An instructional illustration showing a hand grasping the top of a small bottle with an arrow pointing upward, indicating to pull or lift the cap of the bottle. This likely relates to the administration or preparation of an ophthalmic solution.*

FDA Label Image

Ifu Step 4 (Oxervate Step4)

An instructional line drawing showing two hands holding and peeling a single-dose ophthalmic solution container, demonstrating how to open the container for use.*

FDA Label Image

Ifu Steps 5 And 6 (Oxervate Step5 6)

Illustration showing hands removing the cap from a vial by pushing down and pulling up. This likely demonstrates how to open or prepare the vial for use with OXERVATE ophthalmic solution drops (cenegermin-bkbj) 20 mcg/mL.*

FDA Label Image

Ifu Step 7 (Oxervate Step7)

An instructional illustration showing a hand holding an insert or leaflet above an open ophthalmic solution bottle, demonstrating how to place or remove an item associated with the bottle, likely part of the usage or storage instructions.*

FDA Label Image

Ifu Step 8 (Oxervate Step8)

An instructional line drawing showing a hand holding a dropper bottle, positioning it for ophthalmic solution administration. The illustration emphasizes proper handling of the dropper for OXERVATE 20 ug/mL ophthalmic solution/drops.*

FDA Label Image

Ifu Steps 9 And 10 (Oxervate Step9 10)

An instructional illustration showing two steps to open or activate a container. The first step indicates twisting the cap or top component in one direction, and the second step shows pressing down the top. This likely demonstrates how to prepare a single-use ophthalmic solution dropper for use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.